Nuvalent's NVL-655 received FDA Breakthrough Therapy Designation for ALK+ NSCLC, showing potential as a vital therapy. Nuvalent's pipeline includes innovative kinase therapies for NSCLC, with NVL-655 ...
Nvidia Corp. today announced the availability of its newest data center-grade graphics processing unit, the H200 NVL, to power artificial intelligence and high-performance computing. The company ...
CAMBRIDGE, Mass., April 18, 2023 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase ...
CAMBRIDGE, Mass., Feb. 27, 2024 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase ...
At Supercomputing 2024, the AI computing giant shows off what is likely its biggest AI ‘chip’ yet—the four-GPU Grace Blackwell GB200 NVL4 Superchip—while it announces the general availability of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results